Yu‐Ling Chang

943 total citations
19 papers, 590 citations indexed

About

Yu‐Ling Chang is a scholar working on Immunology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Yu‐Ling Chang has authored 19 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Pathology and Forensic Medicine and 4 papers in Molecular Biology. Recurrent topics in Yu‐Ling Chang's work include Systemic Sclerosis and Related Diseases (4 papers), interferon and immune responses (2 papers) and Mesenchymal stem cell research (2 papers). Yu‐Ling Chang is often cited by papers focused on Systemic Sclerosis and Related Diseases (4 papers), interferon and immune responses (2 papers) and Mesenchymal stem cell research (2 papers). Yu‐Ling Chang collaborates with scholars based in United States, Taiwan and China. Yu‐Ling Chang's co-authors include Jonathan Braun, Steven Offenbacher, Timothy C. Nichols, Gary G. Koch, Elizabeth P. Merricks, James D. Beck, Nadine Brodala, Dwight A. Bellinger, Phoebus Madianos and Philip J. Clements and has published in prestigious journals such as Nature Cell Biology, Cancer Research and Annals of Surgery.

In The Last Decade

Yu‐Ling Chang

18 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Ling Chang United States 12 218 133 115 114 103 19 590
Katarina Zeljić Serbia 17 328 1.5× 131 1.0× 82 0.7× 39 0.3× 62 0.6× 32 679
Giovanni Luca Scaglione Italy 16 308 1.4× 58 0.4× 20 0.2× 62 0.5× 103 1.0× 55 677
Vesna Petronic‐Rosic United States 14 122 0.6× 187 1.4× 20 0.2× 184 1.6× 211 2.0× 59 1.2k
Maria Luisa Pacor Italy 20 84 0.4× 236 1.8× 99 0.9× 54 0.5× 221 2.1× 50 1.4k
Mustafa Atasoy Türkiye 16 101 0.5× 191 1.4× 29 0.3× 97 0.9× 138 1.3× 83 848
Heping Zhao China 12 404 1.9× 59 0.4× 20 0.2× 48 0.4× 50 0.5× 33 748
Sven Niklander Chile 16 131 0.6× 50 0.4× 203 1.8× 31 0.3× 68 0.7× 48 642
Hacer Sahin Türkiye 14 171 0.8× 22 0.2× 155 1.3× 253 2.2× 142 1.4× 30 788
Maura Rosane Valério Ikoma Brazil 12 82 0.4× 139 1.0× 23 0.2× 82 0.7× 225 2.2× 34 543
Walter Volpi Italy 21 109 0.5× 419 3.2× 21 0.2× 181 1.6× 572 5.6× 39 1.3k

Countries citing papers authored by Yu‐Ling Chang

Since Specialization
Citations

This map shows the geographic impact of Yu‐Ling Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ling Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ling Chang more than expected).

Fields of papers citing papers by Yu‐Ling Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Ling Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ling Chang. The network helps show where Yu‐Ling Chang may publish in the future.

Co-authorship network of co-authors of Yu‐Ling Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Ling Chang. A scholar is included among the top collaborators of Yu‐Ling Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Ling Chang. Yu‐Ling Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lee, Chia‐Yi, et al.. (2024). The lifestyle and nutritional factors for dry eye disease in depression population: a retrospective case–control study. Frontiers in Medicine. 11. 1376938–1376938.
2.
Chang, Yu‐Ling, Bo‐Ching Lee, Ching‐Chu Lu, et al.. (2023). Strategies for subtyping primary aldosteronism. Journal of the Formosan Medical Association. 123. S114–S124. 4 indexed citations
4.
Zhang, Zhigang, et al.. (2022). Effects of Lycium barbarum glycopeptide on renal and testicular injury induced by di(2-ethylhexyl) phthalate. Cell Stress and Chaperones. 27(3). 257–271. 26 indexed citations
5.
Volkmann, Elizabeth R., Anna‐Maria Hoffmann‐Vold, Yu‐Ling Chang, et al.. (2020). Longitudinal Characterisation of the Gastrointestinal Tract Microbiome in Systemic Sclerosis. European Medical Journal. 7. 110–118. 6 indexed citations
6.
Yan, Kexiang, Yuanjing Zhang, Ling Han, et al.. (2019). Safety and Efficacy of Methotrexate for Chinese Adults With Psoriasis With and Without Psoriatic Arthritis. JAMA Dermatology. 155(3). 327–327. 25 indexed citations
7.
Chang, Yu‐Ling, Maura Rossetti, Hera Vlamakis, et al.. (2018). A screen of Crohn's disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells. Mucosal Immunology. 12(2). 457–467. 50 indexed citations
8.
Sosa, Rebecca A., Maura Rossetti, Bita V. Naini, et al.. (2018). Pattern Recognition Receptor-reactivity Screening of Liver Transplant Patients. Annals of Surgery. 271(5). 922–931. 22 indexed citations
9.
Chung, Lawrance K., Panayiotis E. Pelargos, Ann M. Chan, et al.. (2017). Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas. Brain Tumor Pathology. 35(1). 1–9. 11 indexed citations
10.
Tsui, Jessica, et al.. (2017). Abstract 3965: Epithelial membrane protein-2 is a novel regulator of immune editing in breast cancer. Cancer Research. 77(13_Supplement). 3965–3965. 1 indexed citations
11.
Volkmann, Elizabeth R., Anna‐Maria Hoffmann‐Vold, Yu‐Ling Chang, et al.. (2017). Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts. BMJ Open Gastroenterology. 4(1). e000134–e000134. 77 indexed citations
12.
Chan, Ann M., Yu‐Ling Chang, Anna Matynia, et al.. (2017). Human Embryonic Stem Cell-Derived Mesenchymal Stromal Cells Decrease the Development of Severe Experimental Autoimmune Uveitis in B10.RIII Mice. Ocular Immunology and Inflammation. 26(8). 1228–1236. 11 indexed citations
13.
Volkmann, Elizabeth R., Yu‐Ling Chang, Nashla Barroso, et al.. (2016). Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium. Arthritis & Rheumatology. 68(6). 1483–1492. 91 indexed citations
14.
Volkmann, Elizabeth R., Yu‐Ling Chang, Nashla Barroso, et al.. (2015). OP0213 Systemic Sclerosis is Associated with a Unique Colonic Microbial Consortium. Annals of the Rheumatic Diseases. 74. 151–151. 1 indexed citations
15.
Chang, Yu‐Ling, Ping‐Hui Tseng, Shie‐Liang Hsieh, et al.. (2014). A novel TLR2‐triggered signalling crosstalk synergistically intensifies TNF‐mediated IL‐6 induction. Journal of Cellular and Molecular Medicine. 18(7). 1344–1357. 14 indexed citations
16.
Chio, Iok In Christine, Masato Sasaki, Danny Ghazarian, et al.. (2012). TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation. Nature Cell Biology. 14(6). 625–633. 29 indexed citations
17.
Fu, Shu‐Ling, et al.. (2012). A novel Aurora-A-mediated phosphorylation of p53 inhibits its interaction with MDM2. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1834(2). 508–515. 32 indexed citations
18.
Brodala, Nadine, Elizabeth P. Merricks, Dwight A. Bellinger, et al.. (2005). Porphyromonas gingivalis Bacteremia Induces Coronary and Aortic Atherosclerosis in Normocholesterolemic and Hypercholesterolemic Pigs. Arteriosclerosis Thrombosis and Vascular Biology. 25(7). 1446–1451. 154 indexed citations
19.
Cahill, Ronan A., Martin R. Klemperer, Thomas Mueller, et al.. (2004). Replacement of recipient stromal/mesenchymal cells after bone marrow transplantation using bone fragments and cultured osteoblast-like cells. Biology of Blood and Marrow Transplantation. 10(10). 709–717. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026